Tag
Tag: Blood cancer
Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer
Manufacturing Delays Set Back Autolus’ CAR-T Programs by Five Months
ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment
Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market
This Lab-On-A-Chip Recommends the Best Cancer Treatment In 24 Hours
CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead
Novartis and Gilead’s CAR-T Therapies Now Compete for the Same Cancer Patients
